More on eculizumab for congenital atypical hemolytic-uremic syndrome

Jaeil Shin, Seung Lee Jae

Research output: Contribution to journalLetter

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)2142-2143
Number of pages2
JournalNew England Journal of Medicine
Volume360
Issue number20
DOIs
Publication statusPublished - 2009 May 14

Fingerprint

Complement C5
Hemolytic-Uremic Syndrome
Immunologic Factors
Monoclonal Antibodies
eculizumab
Atypical Hemolytic Uremic Syndrome

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

@article{6490232d306c44158ffec7647dce8d26,
title = "More on eculizumab for congenital atypical hemolytic-uremic syndrome",
author = "Jaeil Shin and Jae, {Seung Lee}",
year = "2009",
month = "5",
day = "14",
doi = "10.1056/NEJMc090453",
language = "English",
volume = "360",
pages = "2142--2143",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "20",

}

More on eculizumab for congenital atypical hemolytic-uremic syndrome. / Shin, Jaeil; Jae, Seung Lee.

In: New England Journal of Medicine, Vol. 360, No. 20, 14.05.2009, p. 2142-2143.

Research output: Contribution to journalLetter

TY - JOUR

T1 - More on eculizumab for congenital atypical hemolytic-uremic syndrome

AU - Shin, Jaeil

AU - Jae, Seung Lee

PY - 2009/5/14

Y1 - 2009/5/14

UR - http://www.scopus.com/inward/record.url?scp=65649103677&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65649103677&partnerID=8YFLogxK

U2 - 10.1056/NEJMc090453

DO - 10.1056/NEJMc090453

M3 - Letter

C2 - 19439754

AN - SCOPUS:65649103677

VL - 360

SP - 2142

EP - 2143

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 20

ER -